Shuwen Biotechnology Overview
- Year Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
Series C2
- Investors
-
10
Shuwen Biotechnology General Information
Description
Manufacturer of innovative in vitro diagnostic products focusing on women's health aims to lead global transformation in pregnancy and cancer screening. The company's offerings feature proprietary diagnostic assays for preeclampsia and breast cancer including the internationally pioneering Whanxian preeclampsia kit and prognostic test, accredited central laboratory services, certified IVD reagent production, and international collaborations, helping clinicians and pharmaceutical developers accelerate diagnosis, personalize treatment, and expand access to advanced womens health testing, enabling improved maternal and oncology outcomes worldwide.
Contact Information
Website
www.shuwendx.comCorporate Office
- Building 3, Number 333 Changhong Middle Street
- Moganshan National High-tech Industrial Development Zone Deqing
- Huzhou, Zhejiang 313200
- China
Corporate Office
- Building 3, Number 333 Changhong Middle Street
- Moganshan National High-tech Industrial Development Zone Deqing
- Huzhou, Zhejiang 313200
- China
Shuwen Biotechnology Timeline
Shuwen Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C2) | 09-Jul-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C1) | 09-Jul-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 02-Jun-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A1) | 09-Apr-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 27-Jul-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 01-Sep-2016 | Completed | Generating Revenue | |||
| 1. Secondary Transaction - Private | 29-Apr-2016 | Completed | Generating Revenue |
Shuwen Biotechnology Patents
Shuwen Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026114286-A1 | Methods and devices for detection of anti-lipoidal antibodies | Pending | 26-Nov-2024 | ||
| WO-2025146204-A1 | Antibiotic-resistant neisseria mutant | Inactive | 04-Jan-2024 | ||
| WO-2025119247-A1 | A method for diagnosing or predicting preeclampsia | Inactive | 04-Dec-2023 | ||
| WO-2023275407-A2 | Method for predicting a clinical response towards an immune checkpoint inhibitor based on pretreatment therewith | Inactive | 02-Jul-2021 | ||
| WO-2023275407-A3 | Method for predicting a clinical response towards an immune checkpoint inhibitor based on pretreatment therewith | Inactive | 02-Jul-2021 | C12Q1/6886 |
Shuwen Biotechnology Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Zhangjiagang Yuefeng Jinchuang Investment | Growth/Expansion | Minority | ||
| Anyuan Fund | Venture Capital | Minority | ||
| CTRL Kaichuang Group | Corporation | Minority | ||
| Guolian Investment | Corporate Venture Capital | Minority | ||
| Wuxi Guolian Development (Group) | Corporation | Minority |
Shuwen Biotechnology FAQs
-
When was Shuwen Biotechnology founded?
Shuwen Biotechnology was founded in 2010.
-
Where is Shuwen Biotechnology headquartered?
Shuwen Biotechnology is headquartered in Huzhou, China.
-
What industry is Shuwen Biotechnology in?
Shuwen Biotechnology’s primary industry is Diagnostic Equipment.
-
Is Shuwen Biotechnology a private or public company?
Shuwen Biotechnology is a Private company.
-
What is Shuwen Biotechnology’s current revenue?
The current revenue for Shuwen Biotechnology is .
-
How much funding has Shuwen Biotechnology raised over time?
Shuwen Biotechnology has raised $29.5M.
-
Who are Shuwen Biotechnology’s investors?
Zhangjiagang Yuefeng Jinchuang Investment, Anyuan Fund, CTRL Kaichuang Group, Guolian Investment, and Wuxi Guolian Development (Group) are 5 of 10 investors who have invested in Shuwen Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process